AZD5438 in Patients with Advanced Solid Malignancies

Study identifier:D0110C00005

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients with Advanced Solid Malignancies

Medical condition

Neoplasms

Phase

Phase 1

Healthy volunteers

No

Study drug

AZD5438

Sex

All

Actual Enrollment

-

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jul 2004
Primary Completion Date: 01 Dec 2005
Study Completion Date: 01 Dec 2005

Study design

Allocation: None
Endpoint Classification: None
Intervention Model: None
Masking: None
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria